Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COVID-19 convalescent plasma (William Beaumont Hospitals)
- Development stage
- Unknown
- Lead developer
- Corewell Health
- Administration
- Intravenous
01
Overview
COVID-19 convalescent plasma (William Beaumont Hospitals) is a biological therapy consisting of plasma collected from individuals who have recovered from COVID-19. This plasma contains neutralizing antibodies, specifically IgG and IgA, against the SARS-CoV-2 virus. The therapy aims to provide passive immunity to hospitalized patients with COVID-19, potentially reducing viral load and improving clinical outcomes. The specific program at William Beaumont Hospitals (now Corewell Health) involved the ABACCuS trial, which evaluated the safety and efficacy of the plasma based on the antibody levels present in the donor units. The study specifically analyzed outcomes in patients requiring supplemental oxygen or mechanical ventilation, correlating recovery with the concentration of anti-SARS-CoV-2 antibodies in the administered plasma.
- Other names
- COVID-19 convalescent plasmaCOVID19 convalescent plasmaCOVID 19 convalescent plasmaConvalescent Plasma
02
Targets
RBD (SARS-CoV-2 spike receptor-binding domain)
Beyond the preview
Go deeper on COVID-19 convalescent plasma (William Beaumont Hospitals).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COVID-19 convalescent plasma (William Beaumont Hospitals).